NANOTEMPER TECHNOLOGIES GMBH

Their core work

NanoTemper Technologies is a Munich-based SME that develops biophysical instrumentation for measuring molecular interactions, protein stability, and binding affinity — tools widely used in pharmaceutical development, biochemistry, and structural biology labs. Within H2020, they serve as an industry partner in Marie Skłodowska-Curie training networks, providing early-stage researchers with access to advanced characterization platforms and real-world industry experience. Their participation spans protein formulation, chemical reaction networks, and neurotransmitter transporter research, reflecting the broad applicability of their measurement technologies across life science disciplines.

What they specialise in

How they've shifted over time

NanoTemper's H2020 journey began in 2016 with protein formulation (PIPPI), a natural fit for a company whose instruments measure protein stability and interactions. From 2019 onward, they expanded into more fundamental research domains — first chemical reaction networks and non-equilibrium systems (CReaNet), then neurotransmitter transporter biology (NeuroTrans). This progression shows a company broadening the application scope of its core measurement technology from pharmaceutical formulation into basic chemical and neurobiological research.

NanoTemper is diversifying from pharma-focused protein characterization toward fundamental life science and chemical biology applications, suggesting they are positioning their instrumentation as a general-purpose molecular measurement platform.

How they like to work

NanoTemper exclusively joins consortia as a partner or third party — never as coordinator — which is typical for an instrumentation SME contributing technology and industry training rather than driving the research agenda. With 30 unique partners across 12 countries from just 3 projects, they operate within large MSCA training networks and are comfortable in multi-national consortia. Their role is consistent: the company that brings the measurement tools and hosts researchers for industry secondments.

Despite only three projects, NanoTemper has built connections with 30 distinct partners across 12 European countries, a consequence of the large consortium sizes typical of MSCA-ITN networks. This gives them a broad but shallow network spanning academic and industrial partners in life sciences.

What sets them apart

NanoTemper occupies a specific niche: they are an instrumentation company that participates in research consortia not to do research themselves, but to provide the measurement infrastructure and industry training environment that training networks need. For consortium builders, they offer a credible German SME partner with commercial-grade biophysical tools, fulfilling the industry participation requirement that MSCA-ITN proposals demand. Their instruments are a common denominator across diverse biological and chemical research, making them a versatile partner for any project requiring molecular interaction or stability measurements.

Highlights from their portfolio

• CReaNet
  Brought biophysical detection capabilities into non-equilibrium chemistry and dissipative self-assembly — an unusual crossover from their typical pharmaceutical domain.
• NeuroTrans
  Most recent project extending their measurement technology into neurotransmitter transporter research, signaling expansion into neuroscience applications.